Mad Money host Jim Cramer dissects what he calls 'abysmal' earnings from McDonald's. He's confident in Chipotle's organic growth.» Read More
Is it time to get short? Jeff Kilburg says yes, but Brian Stutland says that would be like stepping in front of a train. With CNBC's Jackie DeAngelis and the Futures Now Traders.
Gold is up $140 this year. What the jobs number will mean for the precious metal. With CNBC's Jackie DeAngelis and the Futures Now Traders.
Russ Koesterich, global chief investment strategist at BlackRock, says we're at a tender moment for the market. With CNBC's Jackie DeAngelis and the Futures Now Traders.
BlackRock's Russ Koesterich discusses the jobs number and the impact of the weather, as the situation in Ukraine. With CNBC's Jackie DeAngelis and the Futures Now Traders, Brian Stutland & Jeff Kilburg at the CME.
The REIT market barely moved in 2013, explains Gregg Fisher, CIO of Gerstein Fisher. However the REITs are up roughly 10 percent year-to-date, and "investors should diversify globally."
CNBC's Jim Cramer shares his plays on Micron, Joy Global and CSX Corporation
Jim Cramer explains what to watch ahead of the open. Today Cramer has the play on luxury retailer Tiffany.
David Einhorn's Greenlight Capital has increased its bet on Greece's Alpha Bank, making it a top five holding.
You’d think, across the board, buybacks should move the needle, right?
Jim Cramer is always looking at exciting new developments in an attempt to identify larger and investable trends.
Mad Money host Jim Cramer discusses the importance of teaching the youth about personal finance and gives his 3 keys for recent college graduates to keep in mind when investing.
It’s time for the Lightning Round. Cramer makes the call on viewer favorites.
Jim Cramer knows a thing or three about making money. And he’s confident what works for him will work for you, too.
The S&P 500 hit another all-time high this week. Now, some investors are starting to wonder, is the market way ahead of itself?
Mad Money host Jim Cramer explains why the stock market is so "frothy" and examines the "power" of this bull market.
The Fast Money traders share their final trades of the day and what they're looking out for on Thursday.
The Fast Money traders take a look at today's biggest market movers.
Biotech firm Dendreon is set to begin selling its prostate cancer vaccine "Provenge" in Europe. John Johnson, Dendreon chairman & CEO, discusses the European launch and addresses investor concerns.
Teen trader and actor Rachel Fox shares her investment philosophy and favorite stock plays right now. "I focus on whatever is hyped up at the moment," Fox says.
The Fast Money traders discuss the day's top trades and the stocks they are watching, including Exxon and Microsoft. "Exxon is coveted by Russia for their technology and will never get thrown out of there," says trader Tim Seymour.